Actinobacteria: A relevant minority for the maintenance of gut homeostasis

Digestive and Liver Disease - Tập 50 Số 5 - Trang 421-428 - 2018
Cecilia Binda1, Loris Riccardo Lopetuso1, Gianenrico Rizzatti1, Giulia Gibiino1, Vincenzo Cennamo2, Antonio Gasbarrini1
1Department of Internal Medicine, Gastroenterology and Hepatology, Catholic University of Sacred Heart of Rome, A. Gemelli Hospital, Italy
2Unit of Gastroenterology and Digestive Endoscopy, AUSL Bologna Bellaria-Maggiore Hospital, Bologna, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

Mondot, 2013, The human gut microbiome and its dysfunctions, Dig Dis, 31, 278, 10.1159/000354678

Leser, 2009, Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host, Environ Microbiol, 11, 2194, 10.1111/j.1462-2920.2009.01941.x

Neish, 2009, Microbes in gastrointestinal health and disease, Gastroenterology, 136, 65, 10.1053/j.gastro.2008.10.080

Lopetuso, 2016, Gut virome and inflammatory bowel disease, Inflamm Bowel Dis, 22, 1708, 10.1097/MIB.0000000000000807

Donaldson, 2016, Gut biogeography of the bacterial microbiota, Nat Rev Microbiol, 14, 20, 10.1038/nrmicro3552

Guarner, 2003, Gut flora in health and disease, Lancet, 361, 512, 10.1016/S0140-6736(03)12489-0

Arumugam, 2011, Enterotypes of the human gut microbiome, Nature, 473, 174, 10.1038/nature09944

Segata, 2012, Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples, Genome Biol, 13, R42, 10.1186/gb-2012-13-6-r42

D’Aversa, 2013, Gut microbiota and metabolic syndrome, Intern Emerg Med, 8, S11, 10.1007/s11739-013-0916-z

Gallo, 2016, Modulation of microbiota as treatment for intestinal inflammatory disorders: an up-to-date, World J Gastroenterol, 22, 7186, 10.3748/wjg.v22.i32.7186

Round, 2010, Coordination of tolerogenic immune responses by the commensal microbiota, J Autoimmun, 34, J220, 10.1016/j.jaut.2009.11.007

Sekirov, 2010, Gut microbiota in health and disease, Physiol Rev, 90, 859, 10.1152/physrev.00045.2009

Backhed, 2010, Coordinated regulation of the metabolome and lipidome at the host-microbial interface, Biochem Biophys Acta, 1801, 240

Conly, 1994, The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K, Am J Gastroenterol, 89, 915

Younes, 2001, Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats, Br J Nutr, 86, 479, 10.1079/BJN2001430

Scaldaferri, 2012, The gut barrier: new acquisition and therapeutic approaches, J Clin Gastroenterol, 46, S12, 10.1097/MCG.0b013e31826ae849

Purchiaroni, 2013, The role of intestinal microbiota and the immune system, Eur Rev Med Pharmacol Sci, 17, 323

Allen, 2008, Host-microbe communication within the GI tract, Adv Expt Med Biol, 635, 93, 10.1007/978-0-387-09550-9_8

Maynard, 2012, Reciprocal interactions of the intestinal microbiota and immune system, Nature, 489, 231, 10.1038/nature11551

Atarashi, 2013, Treg induction bya rationally selected mixture of Clostridia strains from the human microbiota, Nature, 500, 232, 10.1038/nature12331

Galdean, 2006, The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity, Colin Vaccine Immunol, 13, 219, 10.1128/CVI.13.2.219-226.2006

Sun, 2015, Regulatory immune cells in regulation of intestinal inflammatory response to microbiota, Mucosal Immunol, 8, 969, 10.1038/mi.2015.49

McCarville, 2016, Novel perspectives on therapeutic modulation of the gut microbiota, Therap Adv Gastroenterol, 9, 580, 10.1177/1756283X16637819

Sartor, 2008, Microbial influences in inflammatory bowel disease, Gastroenterology, 134, 577, 10.1053/j.gastro.2007.11.059

De Palma, 2015, Microbiota and host determinants of behavioural phenotype in maternally separated mice, Nat Commun, 6, 7735, 10.1038/ncomms8735

Hill, 2010, Intestinal bacteria and the regulation of immune cell homeostasis, Annu Rev Immunol, 28, 623, 10.1146/annurev-immunol-030409-101330

Cox, 2015, Obesity, inflammation, and the gut microbiota, Lancet Diabetes Endocrinol, 3, 207, 10.1016/S2213-8587(14)70134-2

Koeth, 2013, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat Med, 19, 576, 10.1038/nm.3145

Sun, 2015, Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota, Immunity, 43, 304, 10.1016/j.immuni.2015.07.013

Scher, 2015, Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease, Arthritis Rheumatol, 67, 128, 10.1002/art.38892

Belizario, 2015, Human microbes and their roles in dysbiosis, common disease, and novel therapeutic approaches, Front Microbiol, 6, 1050, 10.3389/fmicb.2015.01050

Adlerberth, 1991, Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants, Acta Paediatr Scand, 80, 602, 10.1111/j.1651-2227.1991.tb11917.x

Hesla, 2014, Impact of lifestyle on the gut microbiota of healthy infants and their mothers – the ALADDIN birth cohort, FEMS Microbiol Ecol, 90, 791, 10.1111/1574-6941.12434

Mitsou, 2008, Fecal microflora of Greek healthy neonates, Anaerobe, 14, 94, 10.1016/j.anaerobe.2007.11.002

Dogra, 2015, Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity, MBio, 6, 10.1128/mBio.02419-14

Huurre, 2008, Mode of delivery – effects on gut microbiota and humoral immunity, Neonatology, 93, 236, 10.1159/000111102

Kabeerdoss, 2013, Development of the gut microbiota in southern Indian infants from birth to 6 months: a molecular analysis, J Nutr Sci, 2, e18, 10.1017/jns.2013.6

Gronlund, 1999, Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery, J Pediatr Gastroenterol Nutr, 28, 19, 10.1097/00005176-199901000-00007

Bezirtzoglou, 1997, The intestinal microflora during the first weeks of life, Anaerobe, 3, 173, 10.1006/anae.1997.0102

Yap, 2011, Evaluation of stool microbiota signatures in two cohorts of Asian (Singapore and Indonesia) newborns at risk of atopy, BMC Microbiol, 11, 193, 10.1186/1471-2180-11-193

Dethlefsen, 2008, The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing, PLoS Biol, 6, e280, 10.1371/journal.pbio.0060280

Penders, 2006, Factors influencing the composition of the intestinal microbiota in early infancy, Pediatrics, 118, 511, 10.1542/peds.2005-2824

Bezirtzoglou, 2011, Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH), Anaerobe, 17, 478, 10.1016/j.anaerobe.2011.03.009

Underwood, 2015, Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut, Pediatr Res, 77, 229, 10.1038/pr.2014.156

Ley, 2006, Ecological and evolutionary forces shaping microbial diversity in the human intestine, Cell, 124, 837, 10.1016/j.cell.2006.02.017

D’Argenio, 2015, The role of the gut microbiome in the healthy adult status, Clin Chim Acta, 451, 97, 10.1016/j.cca.2015.01.003

Eckburg, 2005, Diversity of the human intestinal microbial flora, Science, 308, 1635, 10.1126/science.1110591

Drago, 2012, Cultivable and pyrosequenced fecal microflora in centenarians and young subjects, J Clin Gastroenterol, 46, S81, 10.1097/MCG.0b013e3182693982

Ashida, 2012, Bacterial and host interactions in the gut epithelial barrier, Nature, 489, 231

Hardy, 2013, Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology, Nutrients, 5, 1869, 10.3390/nu5061869

Fukuda, 2012, Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters, Gut Microbes, 3, 449, 10.4161/gmic.21214

Scott, 2014, Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro, FEMS Microbial Ecol, 87, 30, 10.1111/1574-6941.12186

Willemsem, 2003, Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts, Gut, 52, 1442, 10.1136/gut.52.10.1442

Gaudier, 2004, Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose, Am J Physiol Gastrointest Liver Physiol, 287, G1168, 10.1152/ajpgi.00219.2004

Gendler, 1995, Epithelial mucin genes, Annu Rev Physiol, 57, 607, 10.1146/annurev.ph.57.030195.003135

Hamer, 2008, Review article: the role of butyrate on colonic function, Aliment Pharmacy Ther, 27, 104, 10.1111/j.1365-2036.2007.03562.x

Barrett, 2005, A new twist on trefoils. Focus on “TFF3 modulates NF-{kappa}B and a novel regulatory molecule of NF-{kappa}B in intestinal epithelial cells via a mechanism distinct from TNF-{alpha}”, Am J Physiol Cell Physiol, 289, C1069, 10.1152/ajpcell.00340.2005

Song, 2006, Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats, Postgrad Med J, 82, 130, 10.1136/pgmj.2005.037945

Arvans, 2005, Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72, Am J Physiol Gastrointest Liver Physiol, 288, G696, 10.1152/ajpgi.00206.2004

Ren, 2001, Short-chain fatty acids induce intestinal epithelial heat shock protein 25 expression in rats and IEC 18 cells, Gastroenterology, 121, 631, 10.1053/gast.2001.27028

Peng, 2007, Effects of butyrate on intestinal barrier function in a caco-2 cell monolayer model of intestinal barrier, Pediatr Res, 61, 37, 10.1203/01.pdr.0000250014.92242.f3

Mariadason, 1999, Effect of butyrate on paracellular permeability in rat distal colonic mucosa ex vivo, J Gastroenterol Hepatol, 14, 873, 10.1046/j.1440-1746.1999.01972.x

Davila, 2012, Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host, Pharmacol Res, 68, 95, 10.1016/j.phrs.2012.11.005

Bernalier-Donadille, 2010, Fermentative metabolism by the human gut microbiota, Gastroenterol Clin Biol, 34, S16, 10.1016/S0399-8320(10)70016-6

Cummings, 1991, The control and consequences of bacterial fermentation in the human colon, J Appl Microbiol, 70, 443

Hamer, 2012, Functional analysis of colonic bacterial metabolism: relevant to health?, Am J Physiol Gastrointest Liver Physiol, 302, G1, 10.1152/ajpgi.00048.2011

Ponziani, 2017, How to modulate gut microbiota: diet, pre-probiotic or antibiotics?, Minerva Gastroenterol Dietol, 8, 1025

Bindels, 2015, Towards a more comprehensive concept for prebiotics, Nat Rev Gastroenterol Hepatol, 12, 303, 10.1038/nrgastro.2015.47

O’Callaghan, 2016, Bifidobacteria and their role as members of the human gut microbiota, Front Microbiol, 7, 925

Rivière, 2015, Mutual cross-feeding interactions between Bifidobacterium longum NCC2705 and Eubacterium rectale ATCC336656 explain the bifidogenic and butyrogenic effects of arabinoxylan-oligosaccharides, Appl Environ Microbiol, 80, 204, 10.1128/AEM.02853-13

Clausen, 1995, Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis, Gut, 37, 684, 10.1136/gut.37.5.684

Macfarlane, 1986, Starch utilization by the human large intestinal microflora, J Appl Bacteriol, 60, 195, 10.1111/j.1365-2672.1986.tb01073.x

Ryan, 2006, Screening for and identification of starch-, amylopectin-, and pullulan-degrading activities in bifidobacterial strains, Appl Environ Microbiol, 72, 5289, 10.1128/AEM.00257-06

Salyers, 1977, Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon, Appl Environ Microbiol, 34, 529, 10.1128/AEM.34.5.529-533.1977

Pokusaeva, 2011, Carbohydrate metabolism in Bifidobacteria, Genes Nutr, 6, 285, 10.1007/s12263-010-0206-6

El Kaoutari, 2013, The abundance and variety of carbohydrate-active enzymes in the human gut microbiota, Nat Rev Microbol, 11, 497, 10.1038/nrmicro3050

Milani, 2015, Bifidobacteria exhibit social behaviour through carbohydrate resource sharing in the gut, Sci Rep, 5, 15782, 10.1038/srep15782

Raimondi, 2016, Conjugated linoileic acid production by Bifidobacteria: screening, kinetic, and composition, Biomed Res Int, 2016, 8654317, 10.1155/2016/8654317

Kim, 2016, Conjugated linoleic acids: potential health benefits as a functional food ingredient, Annu Rev Food Sci Technol, 7, 221, 10.1146/annurev-food-041715-033028

Cotillard, 2013, Dietary intervention impact on gut microbial gene richness, Nature, 500, 585, 10.1038/nature12480

Turnbaugh, 2008, Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome, Cell Host Microbe, 3, 213, 10.1016/j.chom.2008.02.015

Wu, 2011, Linking long-term dietary patterns with gutmicrobial enterotypes, Science, 334, 105, 10.1126/science.1208344

Teixeira, 2013, Faecal levels of Bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women, Clin Nutr, 32, 1017, 10.1016/j.clnu.2013.02.008

Zimmer, 2012, A vegan or vegetarian diet substantially alters the human colonic faecal microbiota, Eur J Clin Nutr, 66, 53, 10.1038/ejcn.2011.141

Cani, 2007, Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia, Diabetologia, 50, 2374, 10.1007/s00125-007-0791-0

Geurts, 2014, Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics, Benef Microbes, 5, 3, 10.3920/BM2012.0065

Barczynska, 2016, Dextrins from maize starch as substances activating the growth of Bacteroidetes and Actinobacteria simultaneously inhibiting the growth of Firmicutes, responsible for the occurrence of obesity, Plant Foods Hum Nutr, 71, 190, 10.1007/s11130-016-0542-9

Barrett, 2010, Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon, Aliment Pharmacol Ther, 31, 874, 10.1111/j.1365-2036.2010.04237.x

De Giorgio, 2016, Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction?, Gut, 65, 169, 10.1136/gutjnl-2015-309757

McIntosh, 2017, FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial, Gut, 66, 1241, 10.1136/gutjnl-2015-311339

Staudacher, 2012, Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome, J Nutr, 142, 1510, 10.3945/jn.112.159285

Bennet, 2017, Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs, Gut

O’Mahony, 2005, Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles, Gastroenterology, 128, 541, 10.1053/j.gastro.2004.11.050

Whorwell, 2006, Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome, Am J Gastroenterol, 101, 1581, 10.1111/j.1572-0241.2006.00734.x

Guyonnet, 2007, Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial, Aliment Pharmacol Ther, 26, 475, 10.1111/j.1365-2036.2007.03362.x

Sivan, 2015, Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy, Science, 350, 1084, 10.1126/science.aac4255

Duca, 2013, The modulatory role of high fat feeding on gastrointestinal signals in obesity, J Nutr Biochem, 24, 1663, 10.1016/j.jnutbio.2013.05.005

Scarpellini, 2012, Obesity and metabolic syndrome: an inflammatory condition, Dig Dis, 30, 148, 10.1159/000336664

Gauffin Cano, 2013, Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice, Obesity, 21, 2310, 10.1002/oby.20330

Cani, 2009, Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2 driven improvement of gut permeability, Gut, 58, 1091, 10.1136/gut.2008.165886

Zhou, 2009, Signaling mechanism involved in altered function of macrophages from diet-induced obese mice affect immune responses, Proc Natl Acad Sci USA, 106, 10740, 10.1073/pnas.0904412106

Macia, 2006, Impairment of dendritic cell functionally and steady-state number in obese mice, J Immunol, 177, 5997, 10.4049/jimmunol.177.9.5997

O’Mahony, 2008, Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation, PLoS Pathog, 4, e1000112, 10.1371/journal.ppat.1000112

Lyons, 2010, Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models, Clin Exp Allergy, 40, 811, 10.1111/j.1365-2222.2009.03437.x

O’Mahony, 2001, Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice, Aliment Pharmacol Ther, 15, 1219, 10.1046/j.1365-2036.2001.01027.x

Konieczna, 2012, Portrait of an immunoregulatory Bifidobacterium, Gut Microbes, 3, 261, 10.4161/gmic.20358

McCarthy, 2003, Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance, Gut, 52, 975, 10.1136/gut.52.7.975

McKernan, 2010, The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat, Neurogastroenterol Motil, 22, 1029, 10.1111/j.1365-2982.2010.01520.x

Konieczna, 2012, Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells, Gut, 61, 354, 10.1136/gutjnl-2011-300936

Groeger, 2013, Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut, Gut Microbes, 4, 325, 10.4161/gmic.25487

Tojo, 2014, Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis, World J Gastroenterol, 20, 15163, 10.3748/wjg.v20.i41.15163

van der Aa, 2011, Synbad Study Group. Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis, Allergy, 66, 170, 10.1111/j.1398-9995.2010.02416.x

Xiao, 2006, Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial, Clin Exp Allergy, 36, 1425, 10.1111/j.1365-2222.2006.02575.x

Singh, 2013, Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial, Eur J Clin Nutr, 67, 161, 10.1038/ejcn.2012.197

Odamaki, 2007, Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season, J Med Microbiol, 56, 1301, 10.1099/jmm.0.47306-0

Mayer, 2015, Gut/brain axis and the microbiota, J Clin Invest, 125, 926, 10.1172/JCI76304

Grenham, 2011, Brain-gut-microbe communication in health and disease, Front Physiol, 2, 94, 10.3389/fphys.2011.00094

Rhee, 2009, Principles and clinical implications of the brain-gut-enteric microbiota axis, Nat Rev Gastroenterol Hepatol, 6, 306, 10.1038/nrgastro.2009.35

Galland, 2014, The gut microbiome and the brain, J Med Food, 17, 1261, 10.1089/jmf.2014.7000

Lyte, 2014, Microbial endocrinology: host-microbiota neuroendocrine interactions influencing brain and behavior, Gut Microbes, 5, 381, 10.4161/gmic.28682

Borre, 2014, Microbiota and neurodevelopmental windows: implications for brain disorders, Trends Mol Med, 20, 509, 10.1016/j.molmed.2014.05.002

Dinan, 2013, Melancholic microbes: a link between gut microbiota and depression?, Neurogastroenterol Motil, 25, 713, 10.1111/nmo.12198

Bonaz, 2013, Brain-gut interactions in inflammatory bowel disease, Gastroenterology, 144, 36, 10.1053/j.gastro.2012.10.003

Hsiao, 2013, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders, Cell, 155, 1451, 10.1016/j.cell.2013.11.024

Forsythe, 2014, Vagal pathways for microbiome-brain-gut axis communication, Adv Exp Med Biol, 817, 115, 10.1007/978-1-4939-0897-4_5

Mulak, 2015, Brain-gut-microbiota axis in Parkinson's disease, World J Gastroenterol, 21, 10609, 10.3748/wjg.v21.i37.10609

Bailey, 1999, Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys, Dev Psychobiol, 35, 146, 10.1002/(SICI)1098-2302(199909)35:2<146::AID-DEV7>3.0.CO;2-G

Bailey, 2004, Prenatal stress alters bacterial colonization of the gut in infant monkeys, J Pediatr Gastroenterol Nutr, 38, 414, 10.1097/00005176-200404000-00009

Tannock, 1974, Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract, Infect Immun, 9, 591, 10.1128/IAI.9.3.591-598.1974

Suzuki, 1983, Effects of crowding and heat stress on intestinal flora, body weight gain, and feed efficiency of growing rats and chicks, Nippon Juigaku Zasshi, 45, 331, 10.1292/jvms1939.45.331

Goncharova, 1981, Bifidobacterium flora status of cosmonauts before and after completing space flights, Kosm Biol Aviakosm Med, 15, 14

Desbonnet, 2009, The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat, J Psych Res, 43, 164, 10.1016/j.jpsychires.2008.03.009

Desbonnet, 2010, Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression, Neuroscience, 170, 1179, 10.1016/j.neuroscience.2010.08.005

Lyte, 2016, Resistant starch alters the microbiota-gut-brain axis: implications for dietary modulation of behavior, PLOS ONE, 11, e0146406, 10.1371/journal.pone.0146406

Tachon, 2013, The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses, FEMS Microbiol Ecol, 83, 299, 10.1111/j.1574-6941.2012.01475.x

Distrutti, 2014, Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP, PLOS ONE, 9, e106503, 10.1371/journal.pone.0106503

Leclercq, 2014, Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity, Proc Natl Acad Sci USA, 111, e4485, 10.1073/pnas.1415174111

Gionchetti, 2003, Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial, Gastroenterology, 124, 1202, 10.1016/S0016-5085(03)00171-9

Mimura, 2004, Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, Gut, 53, 108, 10.1136/gut.53.1.108

Sood, 2009, The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis, Clin Gastroenterol Hepatol, 7, 1202, 10.1016/j.cgh.2009.07.016

Mardini, 2014, Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis, Inflamm Bowel Dis, 20, 1562, 10.1097/MIB.0000000000000084

Tursi, 2010, Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study, Am J Gastroenterol, 105, 2218, 10.1038/ajg.2010.218

Miele, 2009, Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis, Am J Gastroenterol, 104, 437, 10.1038/ajg.2008.118

Abu-Shanab, 2010, The role of the gut microbiota in nonalcoholic fatty liver disease, Nat Rev Gastroenterol Hepatol, 7, 691, 10.1038/nrgastro.2010.172

Machado, 2012, Gut microbiota and nonalcoholic fatty liver disease, Ann Hepatol, 11, 440, 10.1016/S1665-2681(19)31457-7

Selinger, 2013, Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial, J Hosp Infect, 84, 159, 10.1016/j.jhin.2013.02.019

Ishikawa, 2011, Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study, Digestion, 84, 128, 10.1159/000322977

Kajander, 2005, A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention, Aliment Pharmacol Ther, 22, 387, 10.1111/j.1365-2036.2005.02579.x

Kajander, 2008, Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota, Aliment Pharmacol Ther, 27, 48, 10.1111/j.1365-2036.2007.03542.x

Guandalini, 2010, VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study, J Pediatr Gastroenterol Nutr, 51, 24, 10.1097/MPG.0b013e3181ca4d95

Kleessen, 1997, Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons, Am J Clin Nutr, 65, 1397, 10.1093/ajcn/65.5.1397

Leahy, 2005, Getting better with bifidobacteria, J Appl Microbiol, 98, 1303, 10.1111/j.1365-2672.2005.02600.x

Corrêa, 2005, A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants, J Clin Gastroenterol, 39, 385, 10.1097/01.mcg.0000159217.47419.5b

Patole, 2016, Benefits of Bifidobacterium breve M-16V supplementation in preterm neonates – a retrospective cohort study, PLOS ONE, 11, e0150775, 10.1371/journal.pone.0150775

Chenoll, 2015, Complete genome sequence of Bifidobacterium longum subsp. infantis strain CECT 7210, a probiotic strain active against rotavirus infections, Genome Announc, 3, 10.1128/genomeA.00105-15

Le Leu, 2010, Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats, Carcinogenesis, 31, 246, 10.1093/carcin/bgp197

Rafter, 2007, Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients, Am J Clin Nutr, 85, 488, 10.1093/ajcn/85.2.488

Le Leu, 2005, A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon, J Nutr, 135, 996, 10.1093/jn/135.5.996